# Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

> **NCT05020028** · PHASE2,PHASE3 · RECRUITING · sponsor: **NYU Langone Health** · enrollment: 100 (estimated)

## Conditions studied

- Knee Arthritis

## Interventions

- **DRUG:** Cannabidiol (CBD)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05020028
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-22
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05020028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05020028, "Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05020028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*